secwatch.observer — SEC 8-K summary
======================================

Issuer:     Contineum Therapeutics, Inc. (CTNM)
CIK:        0001855175
Form:       8-K
Filed at:   2025-12-15T23:59:59+00:00
Accession:  0001437749-25-037842
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Contineum prices upsized $90M public offering at $12.25/share; net proceeds ~$84.2M
--------------------------------------------------------------------------------

- 7,346,938 shares of Class A common stock sold at $12.25 per share, up from planned $75M.
- Underwriters have a 30-day option to purchase up to 1,102,040 additional shares.
- Net proceeds estimated at $84.2M after underwriting discounts and expenses.
- Joint book-runners: Goldman Sachs, Leerink Partners, Stifel, RBC, William Blair; Jones as manager.
- Offering closed December 15, 2025, with proceeds for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855175/000143774925037842/0001437749-25-037842-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855175/000143774925037842/ctnm20251214_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-037842

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer